All stock lists
Arbutus Biopharma Corp (ABUS)
United States · Delayed Price · Currency is USD
Pharmaceutical Preparations
4.21+0.01 (+0.36%)
Insider Score
––Not scored
ABUS Insider Score
Insiders here have filed 12 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
ABUS Stock Insider Trading Activity
ABUS stock’s insider trading shows no open-market insider trades by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Androski Lindsay CEO | Option exercise | 116,408 | $3.20 | $372.51K | 416% | 144,408 | Sep 18, 2026 | — | Form 4 |
| Androski Lindsay CEO | Option exercise | 10,456 | $4.39 | $45.90K | 7.2% | 154,864 | Sep 18, 2026 | — | Form 4 |
| Androski Lindsay CEO | Tax withheld | 82,527 | $5.07 | $418.41K | 53.3% | 72,337 | Sep 18, 2026 | — | Form 4 |
| Nguyen Tuan CFO | Option exercise | 265,625 | $3.49 | $927.03K | 361% | 339,125 | Sep 18, 2026 | — | Form 4 |
| Nguyen Tuan CFO | Option exercise | 27,475 | $4.39 | $120.62K | 8.1% | 366,600 | Sep 18, 2026 | — | Form 4 |
| Nguyen Tuan CFO | Tax withheld | 206,637 | $5.07 | $1.05M | 56.4% | 159,963 | Sep 18, 2026 | — | Form 4 |
| Sawhney Roger Director | Option exercise | 52,533 | $3.34 | $175.46K | New | 52,533 | Sep 18, 2026 | — | Form 4 |
| Sawhney Roger Director | Option exercise | 78,800 | $4.24 | $334.11K | 150% | 131,333 | Sep 18, 2026 | — | Form 4 |
| Sawhney Roger Director | Tax withheld | 100,508 | $5.07 | $509.58K | 76.5% | 30,825 | Sep 18, 2026 | — | Form 4 |
| Beardsley Robert A Director | Option exercise | 52,533 | $3.20 | $168.11K | New | 52,533 | Sep 18, 2026 | — | Form 4 |
| Beardsley Robert A Director | Option exercise | 78,800 | $4.24 | $334.11K | 150% | 131,333 | Sep 18, 2026 | — | Form 4 |
| Beardsley Robert A Director | Tax withheld | 99,057 | $5.07 | $502.22K | 75.4% | 32,276 | Sep 18, 2026 | — | Form 4 |
| Nguyen Tuan CFO | Award | 73,500 | — | — | New | 73,500 | Feb 2, 2026 | — | Form 4 |
| Androski Lindsay CEO | Award | 28,000 | — | — | New | 28,000 | Feb 2, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Award (A) — Grant or award from the company, not a purchase
- Tax withheld (F) — Shares withheld to pay tax or an exercise price
- Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.